NEW YORK (GenomeWeb) – BGI today said that it anticipates hiring 100 people for its Hong Kong office this year in order to meet growing business demand.

Established in 2010, BGI-Hong Kong currently employs about 140 people, and is applying for various international quality certifications with plans to conduct personalized genome sequencing for preventing and curing illnesses, BGI said.

"We expect to enter 10 to 20 new overseas markets next year via our Hong Kong research center," Sunny Cheung, laboratory manager of BGI Tech Solutions in Hong Kong, said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.